Recombinant multi-species POMC protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine POMC protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a preproprotein that undergoes extensive, tissue-specific, post-translational processing via cleavage by subtilisin-like enzymes known as prohormone convertases. There are eight potential cleavage sites within the preproprotein and, depending on tissue type and the available convertases, processing may yield as many as ten biologically active peptides involved in diverse cellular functions. The encoded protein is synthesized mainly in corticotroph cells of the anterior pituitary where four cleavage sites are used; adrenocorticotrophin, essential for normal steroidogenesis and the maintenance of normal adrenal weight, and lipotropin beta are the major end products. In other tissues, including the hypothalamus, placenta, and epithelium, all cleavage sites may be used, giving rise to peptides with roles in pain and energy homeostasis, melanocyte stimulation, and immune modulation. These include several distinct melanotropins, lipotropins, and endorphins that are contained within the adrenocorticotrophin and beta-lipotropin peptides. The antimicrobial melanotropin alpha peptide exhibits antibacterial and antifungal activity. Mutations in this gene have been associated with early onset obesity, adrenal insufficiency, and red hair pigmentation. Alternatively spliced transcript variants encoding the same protein have been described. [provided by RefSeq, Jan 2016]
The Alternative Names of target: ACTH,BE,Beta-LPH,CLIP,Clip,Corticotropin-lipotropin,Gamma-LPH,LPH,MSH,NPP,Npp,OBAIRH,POC,POMC,Pomc,Pomc-1,Pomc1,Pomc2,Pro-opiomelanocortin,alpha-MSH,alphaMSH,beta-MSH,gamma-MSH
Go
to POMC products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T62912-Ag-1/ GM-Tg-hg-T62912-Ag-2 | Human POMC protein | Human |
| GM-Tg-rg-T62912-Ag-1/ GM-Tg-rg-T62912-Ag-2 | Rat POMC protein | Rat |
| GM-Tg-mg-T62912-Ag-1/ GM-Tg-mg-T62912-Ag-2 | Mouse POMC protein | Mouse |
| GM-Tg-cynog-T62912-Ag-1/ GM-Tg-cynog-T62912-Ag-2 | Cynomolgus/Rhesus macaque POMC protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T62912-Ag-1/ GM-Tg-felg-T62912-Ag-2 | Feline POMC protein | Feline |
| GM-Tg-cang-T62912-Ag-1/ GM-Tg-cang-T62912-Ag-2 | Canine POMC protein | Canine |
| GM-Tg-bovg-T62912-Ag-1/ GM-Tg-bovg-T62912-Ag-2 | Bovine POMC protein | Bovine |
| GM-Tg-equg-T62912-Ag-1/ GM-Tg-equg-T62912-Ag-2 | Equine POMC protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T62912-Ag-1/ GM-Tg-hg-T62912-Ag-2;
GM-Tg-rg-T62912-Ag-1/ GM-Tg-rg-T62912-Ag-2;
GM-Tg-mg-T62912-Ag-1/ GM-Tg-mg-T62912-Ag-2; GM-Tg-cynog-T62912-Ag-1/ GM-Tg-cynog-T62912-Ag-2; GM-Tg-felg-T62912-Ag-1/ GM-Tg-felg-T62912-Ag-2; GM-Tg-cang-T62912-Ag-1/ GM-Tg-cang-T62912-Ag-2; GM-Tg-bovg-T62912-Ag-1/ GM-Tg-bovg-T62912-Ag-2; GM-Tg-equg-T62912-Ag-1/ GM-Tg-equg-T62912-Ag-2 |
| Products Name | POMC protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | POMC |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine POMC protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.